Results

Total Results: 1,185 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
    December 19, 2016 - So noted Peer Reviewer 5 Methods While the methods are described in infinite detail, much of the description … we do not feel it is a vital part to describe (and describing why 90 days would require additional author … So noted Peer Reviewer 1 General It will be over a year from the literature review end date for eligible … 1 General However, this reviewer is very familiar with a study reviewed because he was the senior author … Peer Reviewer 2 General The report provides a clear and thorough description of the population and
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_disposition-comments.pdf
    September 23, 2014 - I would strongly suggest the authors consider including a pancreatic surgeon as a co-author, as such … We have edited the description of the screening studies. … We have edited the description of the screening studies to avoid giving the impression that we are … As the authors noted, pancreatic cancer has a 6% five-year relative survival rate, partially because
  3. effectivehealthcare.ahrq.gov/products/gout/research-protocol
    November 03, 2014 - Searches will proceed from January 2010 to the present (at least one year to the search dates for the … characteristics necessary to assess risk of bias, including recruitment, blinding, allocation concealment, description … DATABASE SEARCHED & TIME PERIOD COVERED : Web of Science – 1/1/2010-present SEARCH STRATEGY : CITED AUTHOR … : (zhang w*) AND CITED WORK: (ann rheum dis) AND CITED YEAR: (2006) DATABASE SEARCHED & TIME PERIOD … COVERED : SCOPUS – 1/1/2010-present SEARCH STRATEGY : AUTHOR-NAME(zhang w*) AND TITLE-ABS-KEY(gout
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
    October 23, 2014 - The characteristics of the studies are included but further description on the imaging criteria used
  5. effectivehealthcare.ahrq.gov/products/chronic-cough/research-protocol
    January 20, 2012 - These studies adhered to the commonly held concepts of high quality, including the following: a clear description
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
    May 01, 2015 - General I thought this was an interesting report and certainly an area of interest as I was a cited author … Peer Reviewer #8 Methods The description of the methods is clear and concise and outlines how data … We have decided to remove some of the details from this description section and have instead broadened … that showed that printing school forms saved nurses from having to hand write 100,000 dates in one year … Peer Reviewer #7 Findings This is a critically important section since it is the best description
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-acute-chronic_research-protocol.pdf
    February 15, 2017 - studies are deemed to meet inclusion criteria, the following data will be abstracted: study design, year … plan will specify the following elements: • Model structure presented as a graphic or text based description
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - $5 billion, perhaps as much as $17 billion, with roughly $4,624 in costs per woman in the first year … These are rare but ominous: an average of 1,600 new cases occur in the United States each year. … They have poor outcomes with an average 5-year survival of 36 percent if cancer is not isolated to … We categorized interventions using the publication authors’ description. … One small study reported improved bleeding patterns one year after surgery in 12 of 15 women.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
    June 01, 2011 - The findings and conclusions in this document are those of the author(s), who are responsible for its … U.S.), time horizon (e.g., 5 or 10 years), currency (e.g., $, £, €), and year can be fairly readily … of study and 12/31/year of study ‡ U.S. … to $200K/Life year). … NB = net benefit; pEVPI = population expected value of information; WTP = willingness-to-pay Brief description
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
    December 01, 2011 - hospitals and health care facilities have used horizon scanning information to inform their five-year … Disease/Condition Description 5. Technology/Service/Care Innovation Name and Description 6. … Program or Intervention Description 8. Related Names 9. … Horizon Scanning System expects to process expert comments for more than 350 Target Topics in its first year … and comments for up to 240 Target Topics in each subsequent year.
  11. effectivehealthcare.ahrq.gov/products/cancer-ovarian-contraceptives/research-protocol
    February 15, 2012 - Timing: All KQs: Minimum of 1 year of followup from the start of OC use to diagnosis of ovarian cancer … providing the number of expected outcomes per 100,000 women (stratified by OC use) over 5-, 10-, 25-year … outcome(s) in women not using OCs); population estimates are acceptable • Article provides either a description … of the OC formulation(s) used, or a description of the length of OC use Explicit clarification
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
    February 01, 2013 - Table 2 illustrates one such example of how inadequate description of inclusion criteria for a heart … include outright exclusion; inclusion in evidence tables with or without inclusion in a narrative description … assert that reviewers’ knowledge of the identity of the study authors, institution, or journal, or year … Sources of unpublished information for comparative effectiveness reviews Source Description FDA Documents
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - .................................................................................................6 Description … ............................................................................................35 Author … (The SAS Institute, Cary, NC) Effective Health Care Research Report Number 21 6 Results Description … Report Number 21 37 Appendix A: Codes To Identify Chemotherapy Drugs Chemotherapy Regimen HCPC Description … and Hospital Characteristics Cancer End-of-Life Quality Benchmark Measures Data Analysis Results Description
  14. effectivehealthcare.ahrq.gov/products/autism-medical-update/research-protocol
    February 16, 2016 - costs in the billions for an entire birth cohort 8 and an estimated additional cost of $17,000 per year … Interventions to Target Sensory Challenges As noted, we define sensory challenges in line with the broad description … We will extract study and design characteristics (e.g., study design, year, setting, funding source, … severity, treatment history); diagnostic and/or assessment methods; intervention characteristics (e.g., description … References Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for
  15. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
    February 16, 2016 - Published online: February 16, 2016 2   cohort8 and an estimated additional cost of $17,000 per year … Interventions to Target Sensory Challenges As noted, we define sensory challenges in line with the broad description … severity, treatment history); diagnostic and/or assessment methods; intervention characteristics (e.g., description … Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, … Age and IQ at intake as predictors of placement for young children with autism: a four- to six-year
  16. effectivehealthcare.ahrq.gov/products/tinnitus/research-protocol
    February 22, 2012 - studies, including types of study design, descriptions of the study populations (for applicability), description … Y / N Was there a description of withdrawals and dropouts? … a) yes, with independent validation * b) yes, eg record linkage or based on self-reports c) no description … provided of those lost) * c) follow up rate < ____% (select an adequate %) and no description of those … Prognostic factors A clear description of a prognostic factors measured is provided.
  17. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - variables and/or construction of composite endpoints, statistical methods used for data analysis, and a description
  18. effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
    April 12, 2018 - About 2 million U.S. adults experience an osteoporotic or other low- or nontraumatic fracture each year … acid IV Annually 1–3 yr >3 year Biologic Denosumab SC 6 months 1–3 yr >3 year … ≥1 year Setting Any Publication type Published in full text in peer reviewed … extracted, most of which will have been obtained using Distiller during full text eligibility screening: authorDescription of changes in protocol. Justification of why the change will improve the report.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
    May 18, 2011 - The following information will be extracted from each study, where applicable: author identification … , year of publication, source of study funding, study design characteristics, recruitment setting/patient-inclusion … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  20. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - This report is being generated twice a year. … pharmacies range from about $400 to $415 per month or about $4,800 per year, all with the use of a … In August 2011, Pearson and colleagues published 3-year results from a 4-year, multicenter, randomized … Product description: LAP-BAND system. [internet]. Irvine (CA): Allergan, Inc. … Duration-1 three- year and Duration-3 84-week data presented at ADA 2011. [internet].

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: